Fulgent Genetics, Inc. (FLGT) Return on equity 2016–2025
Fulgent Genetics, Inc. (FLGT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-5.4%FY2025 · since FY2016: -9.8% → -5.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -5.4% | -1.7 pp |
| FY2024 | -3.8% | +11.0 pp |
| FY2023 | -14.8% | -26.1 pp |
| FY2022 | 11.3% | -32.5 pp |
| FY2021 | 43.8% | +6.1 pp |
| FY2020 | 37.6% | +38.1 pp |
| FY2019 | -0.5% | +10.5 pp |
| FY2018 | -11.0% | -6.3 pp |
| FY2017 | -4.6% | +5.2 pp |
| FY2016 | -9.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice